GLTO
Galecto Inc

3,102
Loading...
Loading...
Galecto, Inc. is a clinical-stage biotechnology company, which engages in developing novel small molecule therapeutics that are designed to target the biological processes that lie at the heart of cancer and fibrotic diseases. The firm is also involved in the development of small molecule inhibitors of galectin-3 and LOXL2. The company was founded by Ulf Jörgen Nilsson, Hakon Leffler, Tariq Sethi, and Hans Thalsgård Schambye in 2011 and is headquartered in Boston, MA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
5

Frequently Asked Questions

What is Market Cap of Galecto Inc?
What is the 52-week high for Galecto Inc?
What is the 52-week low for Galecto Inc?
What is Galecto Inc stock price today?
What was Galecto Inc stock price yesterday?
What is the PE ratio of Galecto Inc?
What is the Price-to-Book ratio of Galecto Inc?
What is the 50-day moving average of Galecto Inc?
How many employess does Galecto Inc has?

Latest GLTO News

View

Advertisement. Remove ads.

Advertisement. Remove ads.